NCT00732524View on ClinicalTrials.gov

Combination of Sulfonylureas and Insulin Glargine Outpatient Therapy for Unstable Diabetes and Impending DKA

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions

Type 2 Diabetes

Interventions

DRUG

Glipizide

Glipizide XL 10 mg once daily 30 mins before breakfast

DRUG

Glipizide and Glargine

Glipizide XL 10 mg daily 30 minutes before breakfast Insulin Glargine 10 units subcutaneously at bedtime daily

Trial Locations (1)

60612

John H Stroger Hospital Of Cook County, Chicago

All Listed Sponsors

lead

Cook County Health

OTHER_GOV

NCT00732524 - Combination of Sulfonylureas and Insulin Glargine Outpatient Therapy for Unstable Diabetes and Impending DKA | Biotech Hunter | Biotech Hunter